For about 60 percent of patients previously diagnosed with HER2-negative metastatic breast cancer, there may be a treatment available. (Partner Content)

By AstraZeneca Additional protection may be needed for this high-risk population. The COVID-19 pandemic has affected millions of people worldwide,1 especially vulnerable populations such as elderly and immunocompromised people.2 With highly-effective options available to the public, vaccines have reduced the…

How one woman faced an unexpected diagnosis with renewed hope. (Partner Content)

(Partner Content) How a renewed emphasis on partnership among diverse health care stakeholders is transforming how we treat cancer.